Norgine Ventures

Norgine Ventures is a venture capital firm in Hillingdon that focuses on innovations in the healthcare sector. Founded 2012 in Uxbridge, Hillingdon, United Kingdom by Peter Stein, it invests in debt financing, post-IPO debt and venture rounds. Its portfolio companies include PathoQuest, Caresyntax, SpineGuard, EBS Technologies, Collagen Solutions, PulseCath, Q3 Medical Devices, SpineVision, Azanta, and Agendia. As of March 2020, Norgine Ventures has made 15 investments. Their most recent investment was on September 5, 2019, when PathoQuest raised €8M. Norgine Ventures has had six exits, the most notable of which include Caresyntax, SuperSonic Imagine, and SpineGuard.

Norgine Ventures is a venture capital firm in Hillingdon that focuses on innovations in the healthcare sector. Founded 2012 in Uxbridge, Hillingdon, United Kingdom by Peter Stein, it invests in debt financing, post-IPO debt and venture rounds. Its portfolio companies include PathoQuest, Caresyntax, SpineGuard, EBS Technologies, Collagen Solutions, PulseCath, Q3 Medical Devices, SpineVision, Azanta, and Agendia. As of March 2020, Norgine Ventures has made 15 investments. Their most recent investment was on September 5, 2019, when PathoQuest raised €8M. Norgine Ventures has had six exits, the most notable of which include Caresyntax, SuperSonic Imagine, and SpineGuard.